HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability

Oncogene

Volumn 29, Issue 2, 2010, Pages 305-312

  Krishnan, M ^a   Singh, A B ^a   Smith, J J ^a,b   Sharma, A ^a   Chen, X ^a   Eschrich, S ^c   Yeatman, T J ^c   Beauchamp, R D ^a,b   Dhawan, P ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Claudin 1; HDAC; Invasion; Tight junction; TSA

Indexed keywords

BUTYRIC ACID; CLAUDIN 1; HISTONE DEACETYLASE 2; MESSENGER RNA; TRICHOSTATIN A;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; COLON CANCER; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EPIGENETICS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3' UNTRANSLATED REGIONS; BUTYRATES; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; IMMUNOBLOTTING; MEMBRANE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA STABILITY; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 74449085010     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.324     Document Type: Article

References (20)

1. Abuazza G, Becker A, Williams SS, Chakravarty S, Truong HT, Lin F et al. (2006). Claudins 6, 9, and 13 are developmentally expressed renal tight junction proteins. Am J Physiol Renal Physiol 291: F1132-F1141.
2. Chavey C, Muhlbauer M, Bossard C, Freund A, Durand S, Jorgensen C et al. (2008). Interleukin-8 expression is regulated by histone deacetylases through the NF-{kappa}B pathway in breast cancer. Mol Pharmacol 74: 1359-1366.
3. Dhawan P, Singh AB, Deane NG, No Y, Shiou S-R, Schmidt C et al. (2005). Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 115: 1765-1776.
4. Dokmanovic M, Marks PA. (2005). Prospects: histone deacetylase inhibitors. J Cell Biochem 96: 293-304.
5. Godman CA, Joshi R, Tierney BR, Greenspan E, Rasmussen TP, Wang HW et al. (2008). HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling. Cancer Biol Ther 7: 1570-1580.
6. Honda H, Pazin MJ, D'Souza T, Ji H, Morin PJ. (2007). Regulation of the CLDN3 gene in ovarian cancer cells. Cancer Biol Ther 6: 1733-1742.
7. Honda H, Pazin MJ, Ji H, Wernyj RP, Morin PJ. (2006). Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells. J Biol Chem 281: 21433-21444.
8. Liu P-Y, Chan JY-H, Lin H-C, Wang S-L, Liu S-T, Ho C-L et al. (2008). Modulation of the cyclin-dependent kinase inhibitor p21WAF1/Cip1 gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa cells. Mol Cancer Res 6: 1204-1214.
9. Minucci S, Pelicci PG. (2006). Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 6: 38-51.
10. Nishikiori N, Sawada N, Ohguro H. (2008). Prevention of murine experimental corneal trauma by epigenetic events regulating claudin 6 and claudin 9. Jpn J Ophthalmol 52: 195-203.
11. Osanai M, Murata M, Chiba H, Kojima T, Sawada N. (2007a). Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells. Cancer Sci 98: 1557-1562.
12. Osanai M, Murata M, Nishikiori N, Chiba H, Kojima T, Sawada N. (2007b). Occludin-mediated premature senescence is a fail-safe mechanism against tumorigenesis in breast carcinoma cells. Cancer Sci 98: 1027-1034.
13. Pesole G, Mignone F, Gissi C, Grillo G, Licciulli F, Liuni S. (2001). Structural and functional features of eukaryotic mRNA untranslated regions. Gene 276: 73-81.
14. Pryzbylkowski P, Obajimi O, Keen J. (2008). Trichostatin A and 5 Aza-2' deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR. Breast Cancer Res Treat 111: 15-25.
15. Schefe JH, Lehmann KE, Buschmann IR, Unger T, Funke-Kaiser H. (2006). Quantitative real-time RT-PCR data analysis: current concepts and the novel 'gene expression's CT difference' formula. J Mol Med 84: 901-910.
16. Shiou SR, Singh AB, Moorthy K, Datta PK, Washington MK, Beauchamp RD et al. (2007). Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells. Cancer Res 67: 1571-1579.
17. Wu Y, Starzinski-Powitz A, Guo S-W. (2007). Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells. Reprod Sci 14: 374-382.
18. Yamamichi N, Yamamichi-Nishina M, Mizutani T, Watanabe H, Minoguchi S, Kobayashi N et al. (2005). The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential. Oncogene 24: 5471-5481.
19. Zhang Z, Sheng H, Shao J, Beauchamp RD, DuBois RN. (2000). Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells. Neoplasia 2: 523-530.
20. Zhu P, Martin E, Mengwasser J, Schlag P, Janssen K-P, Gottlicher M. (2004). Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5: 455-463.